Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 31, Issue 6, Pages 944-952
Publisher
Oxford University Press (OUP)
Online
2016-05-24
DOI
10.1093/ndt/gfv337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
- (2014) L.M. Camargo et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Effects of Ezetimibe on Endothelial Progenitor Cells and Microparticles in High-Risk Patients
- (2014) Lívia Campos Amaral Lins et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L
- (2014) Fariborz Mobarrez et al. PLATELETS
- Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
- (2013) Suetonia C. Palmer et al. ANNALS OF INTERNAL MEDICINE
- Platelet Hyperaggregability is Highly Prevalent in Patients With Chronic Kidney Disease
- (2013) Eray Yagmur et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes
- (2013) Sara Tehrani et al. Diabetes & Vascular Disease Research
- Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease
- (2013) Tora Almquist et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Haemostasis in chronic kidney disease
- (2013) Jens Lutz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy
- (2013) T. Gremmel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells
- (2013) Rosa Suades et al. THROMBOSIS AND HAEMOSTASIS
- Hyperlipidemia, tissue factor, coagulation, and simvastatin
- (2013) Albert Phillip Owens et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Microparticles: biomarkers and beyond
- (2012) Dylan Burger et al. CLINICAL SCIENCE
- Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial
- (2012) T. Almquist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study
- (2011) Jong Shin Woo et al. AMERICAN HEART JOURNAL
- Microparticles in Hemostasis and Thrombosis
- (2011) A. Phillip Owens et al. CIRCULATION RESEARCH
- Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol
- (2011) R. LACROIX et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study
- (2011) N. Amabile et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease
- (2011) Fariborz Mobarrez et al. THROMBOSIS AND HAEMOSTASIS
- Inflammation and thrombosis in diabetes
- (2011) Katharina Hess et al. THROMBOSIS AND HAEMOSTASIS
- Tissue factor/TFPI and blood cells
- (2011) Bjarne Østerud THROMBOSIS RESEARCH
- Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study
- (2011) Fariborz Mobarrez et al. THROMBOSIS RESEARCH
- Pleiotropic effects of ezetimibe: Do they really exist?
- (2010) Michalis Kalogirou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
- (2010) E. SHANTSILA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia
- (2010) Sara Tehrani et al. THROMBOSIS RESEARCH
- The CD40/CD40 Ligand System
- (2009) Charalambos Antoniades et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A multicolor flow cytometric assay for measurement of platelet-derived microparticles
- (2009) Fariborz Mobarrez et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More